EP0656784A4 - Fragments et analogues d'hormone parathyroidienne. - Google Patents

Fragments et analogues d'hormone parathyroidienne.

Info

Publication number: EP0656784A4
Authority: EP; European Patent Office
Prior art keywords: analogs; parathyroid hormone; hormone fragments; fragments; parathyroid
Prior art date: 1992-08-05
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Withdrawn

Application number

EP93919895A

Other languages

German (de)

English (en)

Other versions

EP0656784A1 (fr

Inventor

Sandra R Hilliker

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Individual

Original Assignee

Individual

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1992-08-05

Filing date

1993-08-05

Publication date

1997-06-04

1993-08-05 Application filed by Individual filed Critical Individual

1995-06-14 Publication of EP0656784A1 publication Critical patent/EP0656784A1/fr

1997-06-04 Publication of EP0656784A4 publication Critical patent/EP0656784A4/fr

Status Withdrawn legal-status Critical Current

Links

102000003982 Parathyroid hormone Human genes 0.000 title 1
108090000445 Parathyroid hormone Proteins 0.000 title 1
239000012634 fragment Substances 0.000 title 1
239000000199 parathyroid hormone Substances 0.000 title 1
229960001319 parathyroid hormone Drugs 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/635—Parathyroid hormone, i.e. parathormone; Parathyroid hormone-related peptides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Pharmacology & Pharmacy (AREA)
Bioinformatics & Cheminformatics (AREA)
General Chemical & Material Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Engineering & Computer Science (AREA)
Physical Education & Sports Medicine (AREA)
Orthopedic Medicine & Surgery (AREA)
Rheumatology (AREA)
Endocrinology (AREA)
Hematology (AREA)
Zoology (AREA)
Gastroenterology & Hepatology (AREA)
Biochemistry (AREA)
Biophysics (AREA)
Genetics & Genomics (AREA)
Molecular Biology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Toxicology (AREA)
Obesity (AREA)
Diabetes (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Peptides Or Proteins (AREA)

EP93919895A 1992-08-05 1993-08-05 Fragments et analogues d'hormone parathyroidienne. Withdrawn EP0656784A4 (fr)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US926070		1986-11-03
US92607092A	1992-08-05	1992-08-05
PCT/US1993/007375 WO1994003201A1 (fr)	1992-08-05	1993-08-05	Fragments et analogues d'hormone parathyroidienne

Publications (2)

Publication Number	Publication Date
EP0656784A1 EP0656784A1 (fr)	1995-06-14
EP0656784A4 true EP0656784A4 (fr)	1997-06-04

Family

ID=25452700

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
EP93919895A Withdrawn EP0656784A4 (fr)	1992-08-05	1993-08-05	Fragments et analogues d'hormone parathyroidienne.

Country Status (4)

Country	Link
EP (1)	EP0656784A4 (fr)
JP (1)	JPH08503692A (fr)
CA (1)	CA2141588A1 (fr)
WO (1)	WO1994003201A1 (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5814603A (en) *	1992-06-12	1998-09-29	Affymax Technologies N.V.	Compounds with PTH activity
DE4434551A1 (de) *	1994-09-28	1996-04-04	Forssmann Wolf Georg Prof Dr D	Peptide aus der Sequenz des hPTH (1-37)
AUPP794898A0 (en) *	1998-12-24	1999-01-28	Garvan Institute Of Medical Research	Transgenic animal
US7820393B2 (en)	1999-01-14	2010-10-26	Scantibodies Laboratory, Inc.	Methods, kits and antibodies for detecting parathyroid hormone
US6689566B1 (en)	1999-01-14	2004-02-10	Scantibodies Laboratory, Inc.	Methods, kits, and antibodies for detecting parathyroid hormone
US6923968B2 (en)	2000-08-10	2005-08-02	Scantibodies Laboratory, Inc.	Cyclase inhibiting parathyroid hormone antagonists or modulators and osteoporosis
WO2004028444A2 (fr)	1999-06-02	2004-04-08	Scantibodies Laboratory, Inc.	Antagonistes de la parathormone et utilisations de ceux-ci
US7056655B2 (en)	2001-11-02	2006-06-06	Scantibodies Laboratory, Inc.	Methods for monitoring and guiding therapeutic suppression of parathyroid hormone in renal patients having secondary hyperparathyroidism
US6524788B1 (en)	2001-11-02	2003-02-25	Thomas L. Cantor	Methods for monitoring and guiding therapeutic suppression of parathyroid hormone in renal patients having secondary hyperparathyroidism
AU2003207512B2 (en)	2002-01-10	2008-06-12	Osteotrophin Llc	Treatment of bone disorders with skeletal anabolic drugs
AU2006315132A1 (en)	2005-11-10	2007-05-24	Board Of Control Of Michigan Technological University	Black bear parathyroid hormone and methods of using black bear parathyroid hormone
JP2013512688A (ja)	2009-12-07	2013-04-18	ミシガンテクノロジカルユニバーシティ	クロクマの副甲状腺ホルモン及びクロクマの副甲状腺ホルモンを使用する方法

Citations (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1993015109A2 (fr) *	1992-02-04	1993-08-05	Boehringer Mannheim Gmbh	Fragments de parathormone, leur fabrication et medicaments les contenant

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4086196A (en) *	1975-03-28	1978-04-25	Armour Pharmaceutical Company	Parathyroid hormone
US4968669A (en) *	1988-05-09	1990-11-06	Merck & Co., Inc.	Parathyroid hormone antagonists

1993
- 1993-08-05 EP EP93919895A patent/EP0656784A4/fr not_active Withdrawn
- 1993-08-05 JP JP6505568A patent/JPH08503692A/ja active Pending
- 1993-08-05 CA CA002141588A patent/CA2141588A1/fr not_active Abandoned
- 1993-08-05 WO PCT/US1993/007375 patent/WO1994003201A1/fr not_active Ceased

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1993015109A2 (fr) *	1992-02-04	1993-08-05	Boehringer Mannheim Gmbh	Fragments de parathormone, leur fabrication et medicaments les contenant

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
CHEMICAL ABSTRACTS, vol. 97, no. 1, 1982, Columbus, Ohio, US; abstract no. 9739388k, CASARETTO MONIKA ET AL.: "Synthesis of two median segments of human parathyrin" page 622; XP002025230 *
FUNAKOSHI, SUSUMU ET AL.: "Studies on peptides. CIX. Synthesis of the Octratricontapeptide corresponding to Positions 1 to 38 of Human Parathyroid Hormone", CHEM. PHARM. BULL., vol. 30, no. 5, 1982, pages 1706 - 17, XP000615407 *
FUNAKOSHI, SUSUMU ET AL.: "Studies on Peptides. CVIII. Synthesis of the Protected Eicosapeptide corresponding to positions 19 to 38 of Human Parathyroid Hormone", CHEM.PHARM. BULL.,, vol. 30, no. 5, 1982, pages 1697 - 705, XP000615406 *
HOPPE-SEYLER'S Z.PHYSIOL.CHEM., vol. 363, no. 4, 1982, pages 407 - 23 *
KIMURA, TERUTHOSHI ET AL.: "Total Synthesis of Human Parathyroid Hormone 1-84)", PEPT. CHEM., vol. 19th, 1981 - 1982, pages 131 - 6, XP000613382 *
See also references of WO9403201A1 *

Also Published As

Publication number	Publication date
CA2141588A1 (fr)	1994-02-17
EP0656784A1 (fr)	1995-06-14
JPH08503692A (ja)	1996-04-23
WO1994003201A1 (fr)	1994-02-17

Legal Events

Date	Code	Title	Description
1995-04-28	PUAI	Public reference made under article 153(3) epc to a published international application that has entered the european phase	Free format text: ORIGINAL CODE: 0009012
1995-06-14	17P	Request for examination filed	Effective date: 19950215
1995-06-14	AK	Designated contracting states	Kind code of ref document: A1 Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE
1996-01-10	RHK1	Main classification (correction)	Ipc: A61K 38/00
1997-05-21	RHK1	Main classification (correction)	Ipc: C07K 5/00
1997-06-04	A4	Supplementary search report drawn up and despatched	Effective date: 19970423
1997-06-04	AK	Designated contracting states	Kind code of ref document: A4 Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE
1997-12-29	17Q	First examination report despatched	Effective date: 19971107
1998-07-24	STAA	Information on the status of an ep patent application or granted ep patent	Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN
1998-09-09	18D	Application deemed to be withdrawn	Effective date: 19980318

Publication	Publication Date	Title
EP0607325A4 (en)	1996-11-06	Parathyroid hormone analogues substituted at aa?25,26,27 and use in osteoporosis treatment.
HU9401798D0 (en)	1994-09-28	Methods for the treatment of osteoporosis using bisphonates and parathyroid hormone
EP0639981A4 (fr)	1995-06-28	Analogues du facteur igf-1.
GB2269176B (en)	1997-01-08	Peptides
AU3095092A (en)	1993-07-19	Stabilized parathyroid hormone composition
EP0580285A3 (fr)	1995-05-03	Auto-réenclencheurs.
EP0602449A3 (fr)	1994-10-19	Carte avec IC.
ZA93505B (en)	1993-08-25	Insecticidally effective peptides.
EP0656784A4 (fr)	1997-06-04	Fragments et analogues d'hormone parathyroidienne.
PL310007A1 (en)	1995-11-13	Insulin analogues
EP0646172A4 (fr)	1997-07-02	Virus entomophiles recombinants.
ZA936811B (en)	1995-03-15	Somatotropin modifications
AU116635S (en)	1993-03-29	Corkscrew
HU9503327D0 (en)	1996-01-29	Arylating medicaments
GB9325519D0 (en)	1994-02-16	Peptides
EP0599191A3 (fr)	1995-02-08	Circuit de régulation de vitesse d'un moteur.
EP0663834A4 (fr)	1996-01-24	Peptides liberant l'hormone de croissance.
LTIP606A (en)	1995-01-31	Peptide compounds, method for the preparation and use thereof
GB2263106B (en)	1995-09-20	Corkscrew
GB9321345D0 (en)	1993-12-08	Instant nail mask
GB2269519B (en)	1995-06-14	Catapult
LTIP608A (en)	1995-01-31	Peptide compounds, method for the preparation and use thereof
ZA939686B (en)	1994-08-29	Transdermal hormone replacement therapy.
GR3017505T3 (en)	1995-12-31	N-Alkyl-3-phenyl-3-(2-alkylthiophenoxy)propylamines.
AU639856C (en)	2001-03-15	Essentially pure human parathyroid hormone